2009, Number S1
<< Back Next >>
Rev Mex Anest 2009; 32 (S1)
Comparative study of postoperative vomiting and nausea
Córdova-López R, Castro-López A, Bastidas-Cuello S
Language: Spanish
References: 13
Page: 131-133
PDF size: 69.77 Kb.
Text Extraction
No abstract
REFERENCES
Kortilla AC, Abdalla M, Kerger H, Turan A, Vedder I, et al. A factorial trial of six interventions for prevention of postoperative nausea and vomiting. N Engl J Med 2004:2441-2451.
Apfel C, Roewer N, Kortilla K. How to study postoperative nausea and vomiting. Acta Anesthesiol Scand 2002;46:921-928
Fisher DM. The big little problem of postoperative nausea and vomiting: Do we know the answer yet? Anesthesiology 1997;87:1271-1273.
Myles PS, Williams DL, Hendrate M, Andersen, Weeks AM. Patient satisfaction after anesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anesth 2000;84:6-10.
Cameron D, Gan TJ. Tratamiento de las náuseas y vómitos postoperatorios en la cirugía ambulatoria; Clínicas de Anestesiología de Norteamérica; Anestesia Ambulatoria 2003:340-341.
Harrison MD, Hasler WL. Náuseas, vómito e indigestión :280.
Andrews PL, Howthorn J. The neurophysiology of vomiting. Bailleres Clin Gastroenterol 1988;2:141-68.
Apfel CC, Kranke P, Katz MH, et al. Volatile, anesthetics may be the main cause of early but no delayed postoperative vomiting: a randomized. BJA 2002;88:659-68.
Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999:91:109-18.
Hbib AS, El-Moalem HE, Gan TJ. The efficacy of the receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexametasone. A meta-analysis of randomized controlled trials. Canadian Journal of Anesthesia 2004;51:311-9.
Arnberger M, Stadelman K, Alisher P, Ponet R, Melber A. Monitoring of neuromuscular blockade at the P6 point, postoperative nausea and vomiting. Anesthesiology 2007;107:903-908.
White P, Scuderi P. Prevention of postoperative nausea and vomiting (NVPO): a dose ranging study involving palonosetron, a potent 5HT3 receptor antagonist. Anesthesiology 2005;101: A703(abstract).
Siddiqui MA, Scott LJ. Palonosetron. Drugs 2004;64:1125-32;discussio33-4.